Bone marrow–derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice
Open Access
- 22 December 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 45 (1) , 213-222
- https://doi.org/10.1002/hep.21477
Abstract
Liver fibrosis is usually progressive, but it can occasionally be reversible if the causative agents are adequately removed or if patients are treated effectively. However, molecular mechanisms responsible for this reversibility of liver fibrosis have been poorly understood. To reveal the contribution of bone marrow (BM)-derived cells to the spontaneous regression of liver fibrosis, mice were treated with repeated carbon tetrachloride injections after hematopoietic reconstitution with enhanced green fluorescent protein (EGFP)-expressing BM cells. The distribution and characteristics of EGFP-positive (EGFP+) cells present in fibrotic liver tissue were examined at different time points after cessation of carbon tetrachloride intoxication. A large number of EGFP+ cells were observed in liver tissue at peak fibrosis, which decreased during the recovery from liver fibrosis. Some of them, as well as EGFP-negative (EGFP−) liver resident cells, expressed matrix metalloproteinase (MMP)-13 and MMP-9. Whereas MMP-13 was transiently expressed mainly in the cells clustering in the periportal areas, MMP-9 expression and enzymatic activity were detected over the resolution process in several different kinds of cells located in the portal areas and along the fibrous septa. Therapeutic recruitment of BM cells by granulocyte colony-stimulating factor (G-CSF) treatment significantly enhanced migration of BM-derived cells into fibrotic liver and accelerated the regression of liver fibrosis. Experiments using transgenic mice overexpressing hepatocyte growth factor (HGF) indicated that G-CSF and HGF synergistically increased MMP-9 expression along the fibrous septa. Conclusion: Autologous BM cells contribute to the spontaneous regression of liver fibrosis, and their therapeutic derivation could be a new treatment strategy for intractable liver fibrosis. (Hepatology; 2007:213–222.)Keywords
This publication has 28 references indexed in Scilit:
- Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis CGastroenterology, 2002
- Regression of Liver Fibrosis after Biliary Drainage in Patients with Chronic Pancreatitis and Stenosis of the Common Bile DuctNew England Journal of Medicine, 2001
- Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachlorideJournal of Hepatology, 2000
- Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon TherapyAnnals of Internal Medicine, 2000
- Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.Journal of Clinical Investigation, 1998
- Reversibility of Hepatic Fibrosis in Autoimmune HepatitisAnnals of Internal Medicine, 1997
- ‘Green mice’ as a source of ubiquitous green cellsFEBS Letters, 1997
- Hepatocyte growth factor in transgenic mice: Effects on hepatocyte growth, liver regeneration and gene expressionHepatology, 1994
- Hepatic FibrosisGastroenterology, 1979
- Collagenase activity in experimental hepatic fibrosisNature, 1974